BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33728801)

  • 1. Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors.
    Siliquini GP; Bounous VE; Novara L; Giorgi M; Bert F; Biglia N
    Breast J; 2021 May; 27(5):448-455. PubMed ID: 33728801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
    Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
    Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Jha S; Wyld L; Krishnaswamy PH
    Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of non-ablative CO
    Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC
    Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
    Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
    Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy.
    Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Faubion SS; Loprinzi CL; Lustberg MB
    Menopause; 2021 Feb; 28(6):642-649. PubMed ID: 33534429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
    Sokol ER; Karram MM
    Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of fractional CO
    Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H
    Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
    Gambacciani M; Levancini M
    Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional CO
    Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
    Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional CO
    Becorpi A; Campisciano G; Zanotta N; Tredici Z; Guaschino S; Petraglia F; Pieralli A; Sisti G; De Seta F; Comar M
    Lasers Med Sci; 2018 Jul; 33(5):1047-1054. PubMed ID: 29492713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
    Mothes AR; Runnebaum M; Runnebaum IB
    J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of fractional CO
    Quick AM; Dockter T; Le-Rademacher J; Salani R; Hudson C; Hundley A; Terstriep S; Streicher L; Faubion S; Loprinzi CL; Coleman JS; Wang KC; Lustberg M
    Maturitas; 2021 Feb; 144():37-44. PubMed ID: 33358206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.